Bumper Offer - Urjas oil Just @ Rs. 1
Derisone Respicap is a commercial drug that is prescribed in the form of Respicaps. Other than this, Derisone Respicap has some other therapeutic uses, which have been discussed ahead.
The right dosage of Derisone Respicap depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
The side effects typically associated with Derisone Respicap include Headache, Increased blood pressure. Such side effects of Derisone Respicap normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Derisone Respicap has a Severe effect for pregnant women and Severe effect on lactating mothers. Further, the section on Derisone Respicap related warnings talks about Derisone Respicap's effects on the liver, heart and kidney.
Other contraindications of Derisone Respicap have been discussed in the sections ahead.
Additionally, Derisone Respicap may also adversely react with other medicines. See below for a complete list.
You should also be aware that Derisone Respicap is safe while driving, and is addiction.
Derisone Respicap is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Derisone Respicap is used -
Common
Is the use of Derisone Respicap safe for pregnant women?
Derisone Respicap can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Derisone Respicap safe during breastfeeding?
Derisone Respicap should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Derisone Respicap on the Kidneys?
Very few cases of side effects of Derisone Respicap on kidney have been reported.
What is the effect of Derisone Respicap on the Liver?
There may be an adverse effect on the liver after taking Derisone Respicap. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Derisone Respicap on the Heart?
There may be an adverse effect on the heart after taking Derisone Respicap. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Derisone Respicap should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Derisone Respicap unless your doctor advises you to do so -
Is this Derisone Respicap habit forming or addictive?
Forming a habit of Derisone Respicap has not been reported.
Interaction between Food and Derisone Respicap
Due to the absence of research, it is difficult to say how Derisone Respicap and food will interact.
Interaction between Alcohol and Derisone Respicap
It is difficult to say anything about the effect of Derisone Respicap and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Qvar® Redihaler™ (beclomethasone dipropionate HFA)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-356
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; QVAR® (beclomethasone dipropionate HFA)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Proventil® HFA (albuterol sulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 118-120